IGI Laboratories Company Profile - Aug 24, 2011 by WrightReports

VIEWS: 13 PAGES: 13

More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   IGI Laboratories, Incorporation
                                                                                     440 Wheelers Farms Road
                                                                                     Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in U.S. Dollars

                                 Wright Quality Rating:LCNN                               Key Data

   IGI Laboratories, Inc. (IGI) is engaged in the formulation, development, manufacture   Ticker:
   and packaging of topical semi-solid and liquid products for pharmaceutical,            IG
   cosmeceutical and cosmetic customers. It serves a range of customers seeking
   product development and/or manufacturing services. The Company offers services         2010 Sales:
   for cosmetic and over-the-counter (OTC) products in liquid, cream and lotion forms.
                                                                                          6,094,000
   IGI have the license to use Novasome Encapsulation technologies from Novavax, Inc.
   (Novavax). The Company would seek to build on the use of Novasome technology in
   topical formulations and intends to pursue collaboration opportunities with            Major Industry:
   pharmaceutical companies seeking to develop topical products with properties.          Drugs, Cosmetics & Health
                                                                                          Care
                       Stock Chart                                 Officers
                                                                  Chairman
                                                                 Joyce Erony              Sub Industry:
                                                                                          Ethical Drug Manufacturers
                                                         President & Chief Executive
                                                               Charles E. Moore      Country:
                                                                                     United States
                                                            Chief Financial Officer
                                                                Jenniffer Collins    Currency:
                                                                                     U.S. Dollars

                                                                                          Fiscal Year Ends:
                                                                                          December

                                                                                          Employees
                                                                                          34

                                                                                          Exchanges:
                                                                                          BSE MSE ASE
             Stock Price (8/19/2011): 1.08
               Recent stock performance                                                   Share Type:
           
								
To top